Skip to main content
OpenTrials
Completed

NCT Number: NCT01328275

Progress Adult Study

The purpose of this study is to study the HIV disease progression in HIV-infected Thai Adult.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

HIV Behavior Behavioral Symptoms Depression

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Bamrasnaradura infectious disease institute, Nonthaburi, Changwat Nonthaburi, Thailand

Loading trial locations.

About this study

This is a multicenter, observational prospective cohort study. All HIV-infected patients from Bamrasnaradura Institute, Sanpatong Hospital and HIV-NAT, Thai Red Cross AIDS Research Centre, are followed to assess HIV disease progression.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • There is evidence that HIV infection true (blood positive results by ELISA (ELISA) has been confirmed or detected evidence co-infection. HIV in the body by PCR, HIV-RNA PCR).Currently on PI regimens
  • Signed consent form
  • Age> 18 years

Exclusion criteria

  • Patients who came for treatment in a department other than out patient, such as inpatient or emergency room.
  • Patients are not willing to receive treatment on a regular basis in all 3 hospitals as patients normally receive treatment at other hospitals on a regular basis. However, due to urgent events. Need to receive treatment in hospital and three of.
  • Patients who have been diagnosed by doctors as a Psychological disorder that can not store the data.
  • Patients who have been diagnosed by a medical condition that Alcoholism

Treatment and study plan

standard regimens according to the Thai Ministry of Public Health national guidelines

Drug

Participants may receive any of the standard regimens. These regimens are recommended in the Thai Ministry of Public Health National guidelines for the treatment of HIV in children. Change of treatment will be according to the treating physicians.

Primary outcomes

  1. HIV related adverse events

    Time frame: 1 year

    Time until patient has HIV related adverse events

Secondary outcomes

  1. Immunological failure

    Time frame: 1 year

    time to immunological failure

  2. virological failure

    Time frame: 1 year

    time to virological failure

  3. the change of quality of life

    Time frame: 1 year

    time to change of quality of life

  4. depression

    Time frame: 1 year

    time when patient develops depression

  5. genotypic resistance

    Time frame: 1 year

    time to developing genotypic resistance

Sponsors and collaborators

Lead sponsor

The HIV Netherlands Australia Thailand Research Collaboration

Other

Collaborators

  • Bamrasnaradura Infectious Diseases Institute
  • Sanpatong Hospital

Registry information

Official study title

The Thai HIV Disease Progression: An Observational Database

Important dates

Study start
2007
Primary completion
2015
Study completion
2015
First posted
Apr 4, 2011
Registry last updated
May 11, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.